Medpace Holdings Inc vs Vanguard International High Dividend Yield ETF — how do they compare? Medpace Holdings Inc trades at $530 (market cap $15.08B), while Vanguard International High Dividend Yield ETF trades at $101.33. The key difference: Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | VYMI | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $620.59 | $101.60 |
52-Week Low | $308.88 | $79.95 |
Enterprise Value | $14.55B | — |
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →